Its involvement in T-cell differentiation and fostering tumor subterfuge from immune scrutiny, primarily through the proliferation of MDSCs, has thrust DKK1 into the spotlight as a prospective linchpin in cancer immunotherapy [19]. Here, DKK1 is linked to neoplasm.